E6 and E7 oncoproteins from human papillomavirus type 16 induce activation of human transforming growth factor β1 promoter throughout Sp1 recognition sequence

Viral Immunology

Volumn 19, Issue 3, 2006, Pages 468-480

  Peralta Zaragoza, Oscar ^a   Bermúdez Morales, Víctor ^a   Gutiérrez Xicotencatl, Lourdes ^a   Alcocer González, Juan ^b   Recillas Targa, Félix ^c   Madrid Marina, Vicente ^a  

^a INSTITUTO NACIONAL DE SALUD PÚBLICA   (Mexico)

^b UNIVERSIDAD AUTÓNOMA DE NUEVO LEÓN   (Mexico)

^c INSTITUTO DE FISIOLOGÍA CELULAR   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; PROTEIN E6; PROTEIN E7; TRANSCRIPTION FACTOR SP1; TRANSFORMING GROWTH FACTOR BETA1;

BINDING SITE; CARCINOGENESIS; CONFERENCE PAPER; CONTROLLED STUDY; DNA SEQUENCE; GENE CONTROL; GENE EXPRESSION; GENE INACTIVATION; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 16; IMMUNE RESPONSE; MOLECULAR RECOGNITION; NONHUMAN; NUCLEOTIDE SEQUENCE; ONCOGENE; PROMOTER REGION; REGULATORY SEQUENCE; TRANSACTIVATION; UTERINE CERVIX CANCER; VIRUS INFECTION;

BASE SEQUENCE; CELL LINE, TUMOR; EXTRACELLULAR MATRIX PROTEINS; HUMAN PAPILLOMAVIRUS 16; HUMANS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS, VIRAL; PROMOTER REGIONS (GENETICS); REPRESSOR PROTEINS; SP1 TRANSCRIPTION FACTOR; TRANS-ACTIVATION (GENETICS); TRANSFORMING GROWTH FACTOR BETA;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33750954562     PISSN: 08828245     EISSN: None     Source Type: Journal    
DOI: 10.1089/vim.2006.19.468     Document Type: Conference Paper

References (44)

1. Antinore MJ, Birrer MJ, Patel D, Nader L, and McCance DJ: The human papillomavirus type 16 E7 gene product interacts with and trans-activates the API family of transcription factors. EMBO J. 1996;15:1950-1960.
2. Chen T, De Vries EG, Hollema H, Yegen HA, Vellucci VF, Strickler HD, Hildesheim A, and Reiss M: Structural alterations of transforming growth factor-β receptor genes in human cervical carcinoma. Int. J. Cancer 1999;82:43-51.
3. Chen X, Ko LJ, Jayaraman L, and Prives C: p53 levels, functional domains, and DNA damage determine the extent of the apoptotic response of tumor cells. Genes Dev. 1996;10:2438-2451.
4. Cheng S, Schmidt-Grimminger DC, Murant T, Broker TR, and Chow LT: Differentiation-dependent up-regulation of the human papillomavirus E7 gene reactivates cellular DNA replication in suprabasal differentiated keratinocytes. Genes Dev. 1995;9:2335-2349.
5. Cho NH, Kim YT, and Kim JW: Alteration of cell cycle in cervical tumor associated with human papillomavirus: Cyclin-dependent kinase inhibitors. Yonsei Med. J. 2002;43:722-728.
6. Chu TY, Lai JS, Shen CY, Liu HS, and Chao CF: Frequent aberration of the transforming growth factor-β receptor II gene in cell lines but no apparent mutation in pre-invasive and invasive carcinomas of the uterine cervix. Int. J. Cancer 1999;80:506-510.
7. Desaintes C, Hallez S, Van Alphen P, and Burny A: Transcriptional activation of several heterologous promoters by the E6 protein of human papillomavirus type 16. J. Virol. 1992;66:325-333.
8. 1 promoter in fibroblasts through a specific GC-rich sequence. Virology 1997;228:190-199.
9. Dick FA, and Dyson NJ: Three regions of the pRb pocket domain affect its inactivation by human papillomavirus E7 proteins. J. Virol. 2002;76:6224-6234.
10. Dignam JD, Lebovitz RM, and Roeder RG: Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 1983;11:1475-1489.
11. Feng XH, Lin X, and Derynck R: Smad2, Smad3 and Smad4 cooperate with Sp1 to induce p15 (Ink4B) transcription in response to TGF-β. EMBO. J. 2000;19:5178-5193.
12. Halbert CL, Demers GW, and Galloway DA: The E6 and E7 genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J. Virol. 1992;66:2125-2134.
13. Kanda T, Furuno A, and Yoshiike K: Human papillomavirus type 16 open reading frame E7 encodes a transforming gene for rat 3Y1 cells. J. Virol. 1988;62:610-613.
14. 1 gene. J. Biol. Chem. 1989;264:402-408.
15. Letterio JJ, and Roberts AB: Regulation of immune responses by TGF-β. Annu. Rev. Immunol. 1998;16:137-161.
16. Li JM, Datto MB, Shen X, Hu PP, Yu Y, and Wang XF: Sp1, but not Sp3, functions to mediate promoter activation by TGF-β through canonical Sp1 binding sites. Nucleic Acids Res. 1998;26:2449-2456.
17. Maldonado E, Cabrejos ME, Banks L, and Allende JE: Human papillomavirus-16 E7 protein inhibits the DNA interaction of the TATA binding transcription factor. J. Cell. Biochem. 2002;85:663-669.
18. Massague J: TGF-β signal transduction. Annu. Rev. Biochem. 1998;67:753-791.
19. Munger K, and Howley PM: Human papillomavirus immortalization and transformation functions. Virus Res. 2002;89:213-228.
20. Nees M, Geoghegan JM, Hyman T, Frank S, Miller L, and Woodworth CD: Papillomavirus type 16 oncogenes downregulate expression of interferon- responsive genes and upregulate proliferation-associated and NF-B-responsive genes in cervical keratinocytes. J. Virol. 2001;75:4283-4296.
21. Nordeen SK, Green PP III, and Fowlkes DM: A rapid, sensitive, and inexpensive assay for chloramphenicol acetyltransferase. DNA 1987;6:173-178.
22. O'Brien PM, and Saveria Campo M: Evasion of host immunity directed by papillomavirus-encoded proteins. Virus Res. 2002;88:103-117.
23. Pasche B: Role of transforming growth factor β in cancer. J. Cell. Physiol. 2001;186:153-168.
24. Phillips AC, and Vousden KH: Analysis of the interaction between human papillomavirus type 16 E7 and the TATA-binding protein, TBP. J. Gen. Virol. 1997;78:905-909.
25. Pouponnot C, Jayaraman L, and Massague J: Physical and functional interaction of SMADs and p300/CBP. J. Biol. Chem. 1998;273:22865-22868.
26. Recillas-Targa F, de Maura Gallo CV, Huesca M, Scherrer K, and Marcaund L: Silencer and enhancer elements located at the 3′-side of the chicken and duck α-globin-encoding gene domains. Gene 1993;129:229-237.
27. Sambrook J, Fritsch EF, and Maniatis T: Chemical sequencing. In: Molecular Cloning: A Laboratory Manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY, 1989, pp. 13.78-13.104.
28. Santin AD, Hermonat PL, Hiserodt JC, Fruehauf J, Schranz V, Barclay D, Pecorelli S, and Parham GP: Differential transforming growth factor-β secretion in adenocarcinoma and squamous cell carcinoma of the uterine cervix. Gynecol. Oncol. 1997;64:477-480.
29. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, and Howley PM: The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990;63:1129-1136.
30. Scott M, Nakagawa M, and Moscicki AB: Cell-mediated immune response to human papillomavirus infection. Clin. Diagn. Lab. Immunol. 2001;8:209-220.
31. Sherman L, and Schlegel R: Serum- and calcium-induced differentiation of human keratinocytes is inhibited by the E6 oncoprotein of human papillomavirus type 16. J. Virol. 1996;70:3269-3279.
32. Stoeck M, Miescher S, MacDonald HR, and Von Fliedner V: Transforming growth factors β slow down cell-cycle progression in a murine interleukin-2 dependent T-cell line. J. Cell. Physiol. 1989;141:65-73.
33. Stopa M, Anhuf D, Terstegen L, Gatsios P, Gressner AM, and Dooley S: Participation of Smad2, Smad3, and Smad4 in transforming growth factor β (TGF-β)-induced activation of Smad7: The TGF-β response element of the promoter requires functional Smad binding element and E-box sequences for transcriptional regulation. J. Biol. Chem. 2000;275:29308-29317.
34. 1 cDNA escapes immune surveillance. Proc. Natl. Acad. Sci. U.S.A. 1990;87:1486-1490.
35. Veldman T, Liu X, Yuan H, and Schlegel R: Human papillomavirus E6 and Myc proteins associate in vivo and bind to and cooperatively activate the telomerase reverse transcriptase promoter. Proc. Natl. Acad. Sci. U.S.A. 2003;100:8211-8216.
36. Von Knebel Doeberitz M, Rittmuller C, zur Hausen H, and Durst M: Inhibition of tumorigenicity of cervical cancer cells in nude mice by HPV E6-E7 anti-sense RNA. Int. J. Cancer 1992;51:831-834.
37. Wakefield LM, and Roberts AB: TGF-β signaling: Positive and negative effects on tumorigenesis. Curr. Opin. Genet. Dev. 2002;12:22-29.
38. Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, Snijders PJ, Peto J, Meijer CJ, and Munoz N: Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J. Pathol. 1999;189:12-19.
39. Woodworth CD, Cheng S, Simpson S, Hamacher L, Chow LT, Broker TR, and DiPaolo JA: Recombinant retroviruses encoding human papillomavirus type 18 E6 and E7 genes stimulate proliferation and delay differentiation of human keratinocytes early after infection. Oncogene 1992;7:619-626.
40. 1 supports autonomous growth of human papillomavirus-immortalized cervical keratinocytes under conditions promoting squamous differentiation. Cell Growth Differ. 1996;7:811-820.
41. Yukawa K, Butz K, Yasui T, Kikutani H, and Hoppe-Seyler F: Regulation of human papillomavirus transcription by the differentiation-dependent epithelial factor Epoc-1/skn-1a. J. Virol. 1996;70:10-16.
42. Zhang B, Li P, Wang E, Brahmi Z, Dunn KW, Blum JS, and Roman A: The E5 protein of human papillomavirus type 16 perturbs MHC class II antigen maturation in human foreskin keratinocytes treated with interferon-γ. Virology 2003;310:100-108.
43. Zimmermann H, Degenkolbe R, Bernard HU, and O'Connor MJ: The human papillomavirus type 16 E6 oncoprotein can down-regulate p53 activity by targeting the transcriptional co-activator CBP/p300. J. Virol. 1999;73:6209-6219.
44. Zur Hausen H: Papillomaviruses and cancer: From basic studies to clinical application. Nat. Rev. Cancer 2002;2:342-350.